-
EP3934654
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3934654
| EP3934654 - ISTAROXIME-CONTAINING INTRAVENOUS FORMULATION FOR THE TREATMENT OF ACUTE HEART FAILURE (AHF) [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 06.10.2023 Database last updated on 13.11.2024 | |
| Former | Request for examination was made Status updated on 10.12.2021 | ||
| Former | The international publication has been made Status updated on 11.09.2020 | ||
| Former | unknown Status updated on 23.01.2020 | Most recent event Tooltip | 05.10.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Windtree Therapeutics, Inc. 2600 Kelly Road Warrington PA 18976 / US | [2022/02] | Inventor(s) | 01 /
BIANCHI, Giuseppe Piazza Adigrat 4 20133 Milano / IT | 02 /
FERRARI, Patrizia Gasparotto 57A 21100 Varese / IT | 03 /
FERRANDI, Mara Via Cenisio 34 20100 Milano / IT | 04 /
BARRASSI, Paolo Via Campagnetta 6/B 21010 Castelveccana (VA) / IT | [N/P] |
| Former [2022/02] | 01 /
BIANCHI, Giuseppe 20133 Milano / IT | ||
| 02 /
FERRARI, Patrizia 21100 Varese / IT | |||
| 03 /
FERRANDI, Mara 20100 Milano / IT | |||
| 04 /
BARRASSI, Paolo 21010 Castelveccana (VA) / IT | Representative(s) | Lock, Graham James Fry Heath & Spence LLP Unit A, Faraday Court Faraday Road Crawley, West Sussex RH10 9PU / GB | [2022/02] | Application number, filing date | 19836196.6 | 12.11.2019 | [2022/02] | WO2019US60961 | Priority number, date | US201962814149P | 05.03.2019 Original published format: US 201962814149 P | [2022/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020180356 | Date: | 10.09.2020 | Language: | EN | [2020/37] | Type: | A1 Application with search report | No.: | EP3934654 | Date: | 12.01.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.09.2020 takes the place of the publication of the European patent application. | [2022/02] | Search report(s) | International search report - published on: | EP | 10.09.2020 | Classification | IPC: | A61K31/5685, A61K45/06, A61P9/00, A61P9/04 | [2022/02] | CPC: |
A61K31/5685 (EP,IL,KR,US);
A61K9/0019 (KR);
A61K45/06 (EP,IL,KR);
A61K9/009 (IL,US);
A61P9/00 (EP,IL);
A61P9/04 (EP,IL,KR,US);
A61P9/06 (IL,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/02] | Title | German: | ISTAROXIMHALTIGE INTRAVENÖSE FORMULIERUNG ZUR BEHANDLUNG VON AKUTEM HERZVERSAGEN (AHV) | [2022/02] | English: | ISTAROXIME-CONTAINING INTRAVENOUS FORMULATION FOR THE TREATMENT OF ACUTE HEART FAILURE (AHF) | [2022/02] | French: | PRÉPARATION INTRAVEINEUSE CONTENANT DE L'ISTAROXIME POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE AIGUË (ICA) | [2022/02] | Entry into regional phase | 01.09.2021 | National basic fee paid | 01.09.2021 | Designation fee(s) paid | 01.09.2021 | Examination fee paid | Examination procedure | 01.09.2021 | Examination requested [2022/02] | 01.09.2021 | Date on which the examining division has become responsible | 19.01.2022 | Amendment by applicant (claims and/or description) | 10.10.2023 | Despatch of a communication from the examining division (Time limit: M04) | 04.01.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 01.09.2021 | Renewal fee patent year 03 | 15.09.2022 | Renewal fee patent year 04 | 29.09.2023 | Renewal fee patent year 05 | 04.10.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]CN103315968B (CVIE THERAPEUTICS COMPANY LTD); | by applicant | US4534899 | EP0825197 | US5846743 | US5874268 | US6007839 | US6063400 | US6261815 | US6384250 | US6589503 | US2004028670 | US2004151766 | US2005136121 | US2006083737 | US7109034 | US2007042031 | US2007077286 | US2007082042 | US2007110798 | US7306783 | CN103315968 |